Abemaciclib
17782
Approved small_molecule completed
Quick answer
Abemaciclib for Breast Neoplasms is a Approved program (small_molecule) at Eli Lilly and Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly and Company
- Indication
- Breast Neoplasms
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed